Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Quasispecies analysis of JC virus DNA present in urine of healthy subjects.
Van Loy T, Thys K, Tritsmans L, Stuyver LJ. Van Loy T, et al. PLoS One. 2013 Aug 15;8(8):e70950. doi: 10.1371/journal.pone.0070950. eCollection 2013. PLoS One. 2013. PMID: 23967139 Free PMC article.
JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.
Van Loy T, Thys K, Ryschkewitsch C, Lagatie O, Monaco MC, Major EO, Tritsmans L, Stuyver LJ. Van Loy T, et al. J Virol. 2015 Jan 15;89(2):1340-7. doi: 10.1128/JVI.02565-14. Epub 2014 Nov 12. J Virol. 2015. PMID: 25392214 Free PMC article.
Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection.
Lagatie O, Van Loy T, Tritsmans L, Stuyver LJ. Lagatie O, et al. Among authors: van loy t. Virol J. 2014 Oct 1;11:174. doi: 10.1186/1743-422X-11-174. Virol J. 2014. PMID: 25273879 Free PMC article.
Viral miRNAs in plasma and urine divulge JC polyomavirus infection.
Lagatie O, Van Loy T, Tritsmans L, Stuyver LJ. Lagatie O, et al. Among authors: van loy t. Virol J. 2014 Sep 2;11:158. doi: 10.1186/1743-422X-11-158. Virol J. 2014. PMID: 25178457 Free PMC article.
Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects.
Lagatie O, Van Loy T, Tritsmans L, Stuyver LJ. Lagatie O, et al. Among authors: van loy t. Virol J. 2014 Mar 3;11:41. doi: 10.1186/1743-422X-11-41. Virol J. 2014. PMID: 24588811 Free PMC article.
An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects.
Stuyver LJ, Verbeke T, Van Loy T, Van Gulck E, Tritsmans L. Stuyver LJ, et al. Among authors: van loy t, van gulck e. Virol J. 2013 Jun 12;10:192. doi: 10.1186/1743-422X-10-192. Virol J. 2013. PMID: 23758776 Free PMC article.
Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors.
Van Hout A, D'huys T, Oeyen M, Schols D, Van Loy T. Van Hout A, et al. Among authors: van loy t. PLoS One. 2017 Apr 14;12(4):e0176057. doi: 10.1371/journal.pone.0176057. eCollection 2017. PLoS One. 2017. PMID: 28410420 Free PMC article.
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry.
Van Hout A, Klarenbeek A, Bobkov V, Doijen J, Arimont M, Zhao C, Heukers R, Rimkunas R, de Graaf C, Verrips T, van der Woning B, de Haard H, Rucker JB, Vermeire K, Handel T, Van Loy T, Smit MJ, Schols D. Van Hout A, et al. Among authors: van loy t. Biochem Pharmacol. 2018 Dec;158:402-412. doi: 10.1016/j.bcp.2018.10.015. Epub 2018 Oct 17. Biochem Pharmacol. 2018. PMID: 30342024
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions.
Bobkov V, Zarca AM, Van Hout A, Arimont M, Doijen J, Bialkowska M, Toffoli E, Klarenbeek A, van der Woning B, van der Vliet HJ, Van Loy T, de Haard H, Schols D, Heukers R, Smit MJ. Bobkov V, et al. Among authors: van loy t. Biochem Pharmacol. 2018 Dec;158:413-424. doi: 10.1016/j.bcp.2018.10.014. Epub 2018 Oct 17. Biochem Pharmacol. 2018. PMID: 30342023 Free article.
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4.
Schoofs G, Van Hout A, D'huys T, Schols D, Van Loy T. Schoofs G, et al. Among authors: van loy t. J Vis Exp. 2018 Mar 10;(133):57271. doi: 10.3791/57271. J Vis Exp. 2018. PMID: 29578516 Free PMC article.
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback